Creso Pharma Limited announced the appointment of Mr. William Lay as Executive Vice President ­ Strategy, Origination & Operations and founder and former director Dr. Miri Halperin Wernli as strategic advisor. Over the last four years, Mr. Lay has overseen and supported over CAD 5 billion in cannabis M&A transactions, including leading the largest acquisition in the history of the cannabis sector. Dr. Halperin Wernli most recently has undertaken the role of the Executive President and Director of US based MindMed Limited, one of the world's largest psychedelic focused companies.